LIFEMED (LMED3) Main Indicators
Basic Data - LMED3
| Company | LIFEMED |
| Corporate Name | LIFEMED INDUSTRIAL EQUIP. DE ART. MÉD. HOSP. S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Bovespa Mais |
| Activity | Fabricação de instrumentos não eletronicos e utensilios para uso médico. odontológico e de laboratório; |
| Share | LMED3 |
| Quote Date | NA |
| Share Type | ON |
| Last Closing | NA |
| Quotation Factor | NA |
| Financial Volume | NA |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Equipamentos |
| Segment | Equipamentos |
| Participation Indexes | - |
| Updated 11/21/2024 | |
Relative Prices - LMED3
| Price/Earnings | 0.00 |
| Price/SBV | 0.00 |
| Price/Net Sales | 0.00 |
| Price/CFO | 0.00 |
| Price/FCF | 0.00 |
| Price/Total Assets | 0.00 |
| Price/EBIT | 0.00 |
| Price/Working Capital | 0.00 |
| Price/NCAV | 0.00 |
| EV/EBIT | NA |
| EV/EBITDA | NA |
| EV/Net Sales | NA |
| EV/CFO | NA |
| EV/FCF | NA |
| EV/Total Assets | NA |
| Company Market Cap | NA |
| Enterprise Value | NA |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 0.00 |
| Share Price Date | //0 |
| Dividend Yield | 0.00% |
| Updated 11/21/2024 | |
Income Statement - LMED3
| Net Revenue | R$ 109.11 M |
| Gross Result | R$ 51.81 M |
| EBIT | R$ 11.91 M |
| Depreciation and Amortization | - R$ 14.63 M |
| EBITDA | R$ 26.54 M |
| Net Profit | - R$ 11.00 M |
| Net Profit/Share | - R$ 4.27 |
| Updated 11/14/2024 | |
| Net Revenue | R$ 33.76 M |
| Gross Result | R$ 15.53 M |
| EBIT | R$ 2.74 M |
| Depreciation and Amortization | - R$ 3.66 M |
| EBITDA | R$ 6.40 M |
| Net Profit | - R$ 2.43 M |
| Profit/Share | - R$ 0.94 |
| Updated 11/14/2024 | |
Price and Volume Behavior - LMED3
There are no quotes for this ticker.
Returns and Margins - LMED3
| Return on Initial Tangible Capital | 2.73% |
| Return on Initial Invested Capital | 2.69% |
| Pre-Tax Return on Initial Tangible Capital | 4.13% |
| Pre-Tax Return on Initial Invested Capital | 4.08% |
| Return on Initial Shareholder´s Equity | -6.86% |
| Return on Initial Asset | -3.09% |
| Gross Margin | 47.49% |
| Net Margin | -10.08% |
| EBIT Margin | 10.91% |
| EBITDA Margin | 24.32% |
| Initial Asset Turnover | 0.31 |
| Financial Leverage | 2.02 |
| Liabilities/Net Worth | 1.02 |
| Net Debt/EBITDA | 3.66 |
| Updated 11/14/2024 | |
Balance Sheet - LMED3
| Cash and Cash Equivalents | R$ 316.00 thousand |
| Total Assets | R$ 300.61 M |
| Short-Term Debt | R$ 34.33 M |
| Long-Term Debt | R$ 63.22 M |
| Gross Debt | R$ 97.55 M |
| Net Debt | R$ 97.24 M |
| Shareholder´s Equity | R$ 149.17 M |
| Share Book Value | R$ 57.90 |
| Common Shares | 2,576,438 |
| Preferred Shares | 0 |
| Total | 2,576,438 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 2,576,438 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 2,576,438 |
| Updated 11/14/2024 | |
Cash Flow - LMED3
| Operating Cash Flow | R$ 101.25 M |
| Cash Flow from Investments | - R$ 44.71 M |
| Financing Cash Flow | - R$ 56.63 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 85.00 thousand |
| Updated 11/14/2024 | |
| Operating Cash Flow | R$ 13.20 M |
| Cash Flow from Investments | - R$ 19.67 M |
| Financing Cash Flow | R$ 6.67 M |
| Increase (Reduction) in Cash and Equivalents | R$ 197.00 thousand |
| Updated 11/14/2024 | |
Experimental - LMED3
| CAPEX 3 months | - R$ 10.40 M |
| Free Cash Flow 3 months | R$ 2.80 M |
| CAPEX 12 months | - R$ 34.27 M |
| Free Cash Flow 12 months | R$ 66.98 M |
| Updated 11/14/2024 | |
Quote Chart - LMED3
There are no quotes for this ticker.